Medicine
Bumetanide 2 mg tablet
Bumetanide 2 mg tablet is a generic prescription medicine for oral use, made by 21 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 68° to 77°F (20° to 25°C), excursions permitted between 59° to 86°F…
Key facts
- Active ingredient (INN)
- Bumetanide
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 30 tablets and 53 more
- Manufacturers
- Zydus LifesciencesIndiaAvet PharmaceuticalsIndiaLifestar PharmaIndiaNovadoz PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaA-S Medication SolutionsSandozAmneal Pharmaceuticals NYEdenbridge PharmaceuticalsExelan Pharmaceuticals21 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 68° to 77°F (20° to 25°C), excursions permitted between 59° to 86°F (15° to 30°C).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03CA02 Bumetanide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 November 1996
- Identifiers
- RxCUI 197417, 197418, 197419DailyMed set ID 32c4372e-54ea-4fc8-b9f8-827fa4c8edd3, 4bcc6cdb-3dfa-4757-bac2-a2dc8bd3a9f6, dfa1f77d-8209-48e9-a6c7-d3b4725a97db +29NDC 42799-121, 43547-898, 50090-7350 +29Application NDA018225, ANDA212931, ANDA209916 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 21 labelers. The register lists 56 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 68382-527-01 | Zydus LifesciencesIndia | 1 May 2018 |
| 500 tablet in 1 bottle | 68382-527-05 | Zydus LifesciencesIndia | 1 May 2018 |
| 30 tablet in 1 bottle | 68382-527-06 | Zydus LifesciencesIndia | 1 May 2018 |
| 1000 tablet in 1 bottle | 68382-527-10 | Zydus LifesciencesIndia | 1 May 2018 |
| 90 tablet in 1 bottle | 68382-527-16 | Zydus LifesciencesIndia | 1 May 2018 |
| 1000 tablet in 1 bottle | 70771-1026-0 | Zydus LifesciencesIndia | 1 May 2018 |
| 100 tablet in 1 bottle | 70771-1026-1 | Zydus LifesciencesIndia | 1 May 2018 |
| 30 tablet in 1 bottle | 70771-1026-3 | Zydus LifesciencesIndia | 1 May 2018 |
| 500 tablet in 1 bottle | 70771-1026-5 | Zydus LifesciencesIndia | 1 May 2018 |
| 90 tablet in 1 bottle | 70771-1026-9 | Zydus LifesciencesIndia | 1 May 2018 |
| 100 tablet in 1 bottle | 23155-902-01 | Avet PharmaceuticalsIndia | 28 June 2024 |
| 500 tablet in 1 bottle | 23155-902-05 | Avet PharmaceuticalsIndia | 28 June 2024 |
| 1000 tablet in 1 bottle | 23155-902-10 | Avet PharmaceuticalsIndia | 28 June 2024 |
| 100 tablet in 1 bottle | 70756-081-11 | Lifestar PharmaIndia | 3 April 2025 |
| 500 tablet in 1 bottle | 70756-081-51 | Lifestar PharmaIndia | 3 April 2025 |
| 500 tablet in 1 bottle | 72205-058-05 | Novadoz PharmaceuticalsIndia | 10 February 2026 |
| 100 tablet in 1 bottle | 72205-058-91 | Novadoz PharmaceuticalsIndia | 10 February 2026 |
| 100 tablet in 1 bottle | 51672-4225-1 | Sun Pharmaceutical IndustriesIndia | 24 July 2023 |
| 100 tablet in 1 bottle | 0185-0130-01 | Sandoz | 21 November 1996 |
| 500 tablet in 1 bottle | 0185-0130-05 | Sandoz | 21 November 1996 |
| 100 tablet in 1 bottle | 0781-8160-01 | Sandoz | 28 September 2026 |
| 100 tablet in 1 bottle | 72888-021-01 | Advagen Pharma | 16 January 2025 |
| 100 tablet in 1 bottle | 69238-1491-1 | Amneal Pharmaceuticals NY | 18 October 2017 |
| 500 tablet in 1 bottle | 69238-1491-5 | Amneal Pharmaceuticals NY | 18 October 2017 |
| 100 tablet in 1 bottle | 42799-121-01 | Edenbridge Pharmaceuticals | 15 October 2015 |
| 500 tablet in 1 bottle | 42799-121-02 | Edenbridge Pharmaceuticals | 15 October 2015 |
| 100 tablet in 1 bottle | 76282-799-01 | Exelan Pharmaceuticals | 1 March 2025 |
| 500 tablet in 1 bottle | 76282-799-05 | Exelan Pharmaceuticals | 1 March 2025 |
| 100 tablet in 1 bottle | 81469-223-01 | First Nation Group | 19 February 2026 |
| 500 tablet in 1 bottle | 81469-223-05 | First Nation Group | 19 February 2026 |
| 100 tablet in 1 bottle | 16571-677-01 | Rising Pharma Holdings | 3 June 2024 |
| 1000 tablet in 1 bottle | 16571-677-10 | Rising Pharma Holdings | 3 June 2024 |
| 100 tablet in 1 bottle | 43547-898-10 | Solco Healthcare | 1 March 2025 |
| 500 tablet in 1 bottle | 43547-898-50 | Solco Healthcare | 1 March 2025 |
| 90 tablet in 1 bottle | 50090-5663-0 | A-S Medication Solutions | 15 September 2021 |
| 90 tablet in 1 bottle | 50090-6137-0 | A-S Medication Solutions | 3 October 2022 |
| 90 tablet in 1 bottle | 50090-6304-0 | A-S Medication Solutions | 29 December 2022 |
| 90 tablet in 1 bottle | 50090-7350-0 | A-S Medication Solutions | 16 October 2024 |
| 90 tablet in 1 bottle | 50090-7854-0 | A-S Medication Solutions | 12 January 2026 |
| 90 tablet in 1 bottle | 50090-7876-0 | A-S Medication Solutions | 2 February 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 February 1983 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Bumetanide 2 mg tablet.
Other strengths and forms of Bumetanide
Clinical summary
Bumetanide is a loop diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. MedsAcross supplies Bumetanide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BumetanideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Bumetanide prescribing information (Edenbridge Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Bumetanide 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.